Opportunity Information: Apply for PAR 16 045
Apply for PAR 16 045
- The HHS-NIH11 in the health sector is offering a public funding opportunity titled "Planning Grant for Emerging Epidemic Virus Research Training for West African Countries with Widespread Transmission of Ebola- Guinea, Liberia, and Sierra Leone (D71)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.989,.
- This funding opportunity was created on Nov 24, 2015 and posted on Nov 24, 2015.
- Applicants must submit their applications by Feb 24, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Public and State controlled institutions of higher education, Private institutions of higher education, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Planning Grant for Emerging Epidemic Virus Research Training for West African Countries with Widespread Transmission of Ebola (D71) is a U.S. National Institutes of Health (NIH), Department of Health and Human Services (HHS) funding opportunity designed to help research institutions lay the groundwork for long-term, sustainable research training and capacity building in West Africa, specifically through partnerships involving Guinea, Liberia, and/or Sierra Leone. The program is framed around the lessons and urgent needs highlighted by the Ebola epidemic and is aimed at strengthening the region's ability to respond to future viral threats that could spread regionally or globally.
This announcement (Funding Opportunity Number PAR-16-045) supports planning activities rather than full implementation. Applicants are expected to propose a structured, collaborative planning process that brings together U.S. and/or African research institutions with partner institutions in the affected West African countries. The core purpose is to design future research training approaches that build durable local capacity, not only for immediate outbreak response but also for the scientific and public health work needed before, during, and after epidemics. The emphasis is on developing training and capacity building concepts that enable early identification of emerging viral diseases, improved prediction of transmission patterns, evidence-based testing of public health responses, and the ability to assess and address long-term health sequelae in survivors and affected communities.
In practical terms, the planning supported by this grant is meant to result in a coherent roadmap for research training: what types of trainees will be developed (for example, investigators, laboratory scientists, data analysts, epidemiologists, clinical researchers, or implementation researchers), what competencies and curricula are needed, what institutional resources and mentorship structures must be in place, and how collaborations will be organized to ensure skills and infrastructure remain in-country over time. The opportunity focuses on emerging viral epidemics broadly, using Ebola-affected settings as the immediate collaboration priority, while keeping an eye on other viral threats with pandemic potential.
Eligibility is open to a range of higher education institutions, including public or state-controlled universities and private universities, with additional eligibility categories referenced in the announcement. The funding mechanism is a discretionary grant under NIH's health-related research and training mission (CFDA numbers 93.989). The award ceiling is listed at $50,000, reflecting that this is a limited, planning-oriented grant rather than a large-scale program award. NIH anticipated making about 10 awards under this opportunity.
Key administrative details include an original and current closing date of February 24, 2016, with the opportunity created and posted on November 24, 2015. Overall, this FOA is best understood as a catalyst for building well-designed, partner-driven training programs that can later be scaled into full research training and capacity strengthening efforts, ultimately improving the ability of Guinea, Liberia, and Sierra Leone to detect, study, and manage emerging viral epidemic threats and their longer-term impacts.
Frequently Asked Questions (FAQs)
What is the Planning Grant for Emerging Epidemic Virus Research Training for West African Countries with Widespread Transmission of Ebola (D71)?
This is a U.S. National Institutes of Health (NIH), Department of Health and Human Services (HHS) funding opportunity intended to support planning activities that lay the groundwork for long-term, sustainable research training and capacity building in West Africa. It is framed around lessons and needs highlighted by the Ebola epidemic.
What is the funding opportunity number for this announcement?
The Funding Opportunity Number is PAR-16-045.
Who is the sponsoring agency?
The sponsoring agency is the U.S. National Institutes of Health (NIH) within the Department of Health and Human Services (HHS).
What is the main purpose of this grant?
The main purpose is to support a structured, collaborative planning process that designs future research training approaches and capacity building concepts that remain in-country over time, strengthening the ability to respond to future viral threats that could spread regionally or globally.
Is this grant meant to fund full program implementation?
No. This announcement supports planning activities rather than full implementation. The expected output is a coherent roadmap for future research training and capacity strengthening efforts.
Which countries are specifically prioritized for partnership under this opportunity?
The opportunity specifically emphasizes partnerships involving Guinea, Liberia, and/or Sierra Leone, described as West African countries with widespread Ebola transmission.
Does the opportunity focus only on Ebola?
The focus is on emerging viral epidemics broadly, using Ebola-affected settings as the immediate collaboration priority while also keeping other viral threats with pandemic potential in view.
What kinds of activities are expected to be supported during the planning phase?
Applicants are expected to propose a structured planning process to design research training approaches and capacity building concepts. The planning is meant to define trainees, competencies, curricula, mentorship structures, institutional resources, and collaboration models that help ensure skills and infrastructure remain in-country over time.
What outcomes is the planned training and capacity building intended to support?
The designed approaches are intended to enable early identification of emerging viral diseases, improved prediction of transmission patterns, evidence-based testing of public health responses, and the ability to assess and address long-term health sequelae in survivors and affected communities.
What types of trainees might be included in the future training roadmap?
The roadmap may cover multiple trainee types, such as investigators, laboratory scientists, data analysts, epidemiologists, clinical researchers, and implementation researchers.
What elements should the planning roadmap address?
Based on the description, the roadmap should address (1) which types of trainees will be developed, (2) what competencies and curricula are needed, (3) what institutional resources and mentorship structures must be in place, and (4) how collaborations will be organized to keep skills and infrastructure sustainable and in-country over time.
What kinds of organizations are eligible to apply?
Eligibility is open to a range of higher education institutions, including public or state-controlled universities and private universities. The announcement also references additional eligibility categories.
What is the funding mechanism and program classification mentioned?
The opportunity is described as a discretionary grant under NIH's health-related research and training mission, and it references CFDA numbers 93.989.
What is the maximum award amount (award ceiling)?
The award ceiling is listed at $50,000, reflecting that this is a limited, planning-oriented grant rather than a large-scale program award.
How many awards did NIH anticipate making?
NIH anticipated making about 10 awards under this opportunity.
What are the key dates for this funding opportunity?
The opportunity was created and posted on November 24, 2015. The original and current closing date is February 24, 2016.
What is the broader goal of this planning grant in the region?
The broader goal is to catalyze well-designed, partner-driven training programs that can later be scaled into full research training and capacity strengthening efforts, improving the ability of Guinea, Liberia, and Sierra Leone to detect, study, and manage emerging viral epidemic threats and their longer-term impacts.
What does "partner-driven" and "sustainable" mean in the context provided?
In the context provided, it means designing collaborations, training, and supporting resources in a way that ensures skills and infrastructure remain in the affected West African countries over time, rather than being dependent on short-term external support.
Does the description indicate whether partners must include U.S. institutions, African institutions, or both?
The description states that planning should bring together U.S. and/or African research institutions with partner institutions in the affected West African countries.
Browse more opportunities from the same agency: HHS-NIH11
Browse more opportunities from the same category: Health
Next opportunity: Strengthening Care and Support Services for Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Côte d’Ivoire Under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Drug Discovery For Nervous System Disorders (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 16 045
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 16 045) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Care and Support Services for Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Côte d’Ivoire Under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10290501SUPP16 Funding Number: CDC RFA PS10 10290501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $4,312,949 |
| Grants to Expand Care Coordination Targeted Capacity Expansion (TCE) through the Use of Technology Assisted Care (TAC) in Targeted Areas of Need (Short Title: TCE-TAC) Apply for TI 16 001 Funding Number: TI 16 001 Agency: HHS-SAMHS Category: Health Funding Amount: $280,000 |
| Licensure Portability Grant Program Apply for HRSA 16 014 Funding Number: HRSA 16 014 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Nutrition Strategies to Address Micronutrient Deficiencies Apply for CDC RFA DP16 1603 Funding Number: CDC RFA DP16 1603 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $1,000,000 |
| Precision Medicine Initiative Cohort Program Coordinating Center (U2C) Apply for RFA PM 16 001 Funding Number: RFA PM 16 001 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| PEPFAR Small Grants Program 2015-2016, U.S. Embassy Maseru Apply for DOS MSU PFSGP FY16 Funding Number: DOS MSU PFSGP FY16 Agency: DOS-MLS Category: Health Funding Amount: $25,000 |
| National Foundation for the Centers for Disease Control and Prevention Apply for CDC RFA CD16 1601 Funding Number: CDC RFA CD16 1601 Agency: HHS-CDC-OD Category: Health Funding Amount: $1,250,000 |
| Reinforcing HIV Clinical Services within a Network of Faith-based Health Institutions in Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1710 Funding Number: CDC RFA GH16 1710 Agency: HHS-CDC-CGH Category: Health Funding Amount: $5,500,000 |
| Pediatric Diagnostic Biomarkers for Active Pulmonary TB Disease (R01) Apply for RFA AI 15 057 Funding Number: RFA AI 15 057 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Building Health Sector Capacity for HIV/AIDS Prevention, Care, and Treatment Interventions and Coordination in the Republic of Côte d’Ivoire under the President’s Emergency Plan for AIDS Relief Apply for CDC RFA PS10 10360501SUPP16 Funding Number: CDC RFA PS10 10360501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $1,088,129 |
| HIV/AIDS Vaccine Scholars Program (K01) Apply for PAR 16 028 Funding Number: PAR 16 028 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35) Apply for RFA DE 17 002 Funding Number: RFA DE 17 002 Agency: HHS-NIH11 Category: Health Funding Amount: $650,000 |
| Maternal, Infant and Early Childhood Home Visiting Program - Formula Apply for HRSA 16 172 Funding Number: HRSA 16 172 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01) Apply for PAR 16 020 Funding Number: PAR 16 020 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Conducting Public Health Research in Thailand: technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH) Apply for RFA GH 16 003 Funding Number: RFA GH 16 003 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $7,000,000 |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76) Apply for RFA AG 16 023 Funding Number: RFA AG 16 023 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Fogarty Global Injury and Trauma Research Training Program (D43) Apply for RFA TW 16 001 Funding Number: RFA TW 16 001 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Conducting Public Health Research through Field Epidemiology and Laboratory Training Programs Apply for RFA GH 11 00105CONT16 Funding Number: RFA GH 11 00105CONT16 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| MCH Research Network on Promoting Healthy Weight among Children with Autism Spectrum Disorder and other Developmental Disabilities Apply for HRSA 16 044 Funding Number: HRSA 16 044 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Study to Assess the Incidence of Type 1 Diabetes in Young Adults Apply for RFA DP 16 005 Funding Number: RFA DP 16 005 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 16 045", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.